Clinical Data Secures EU Patent For MDR1 - A Key Multi-Drug Resistance Gene
Jul 4th 2008Drug InformationPharma Industry
Clinical Data, Inc. (NASDAQ: CLDA), a leader in the development of targeted therapeutics and predictive tests from its growing portfolio of proprietary genetic biomarkers, announced today that the European Patent Office has granted Patent No. 1232260 to Bernried, Germany-based Epidauros Biotechnologie AG, a wholly-owned subsidiary of Clinical Data, relating to the use of a genetic variant, or biomarker, of the gene MDR1 (also known as ABCB1), which encodes P-glycoprotein (PGP).
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
